“Leading journal presents in vitro studies for endogenous Ciliate lipases as therapeutic candidates for oral treatment of exocrine pancreatic insufficiency (EPI). Münster, Germany, October 20th 2016, Cilian AG, a biopharmaceutical company focused on the development of subunit vaccines, enzymes and monoclonal antibodies, announces that the European Journal of Gastroenterology & Hepatology, the international, peer-reviewed, online publication journal, has published an article entitled: Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency.”